Cure My Disease

Don't miss your cure!

 Log in / Sign up

Instagram program aims to curb opioid misuse in young adults

NCT ID NCT06469749

Not yet recruiting Knowledge-focused Sponsor: University of South Carolina Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a 12-week Instagram program led by trained peers to help young adults (ages 18-25) who misuse prescription opioids. Participants will receive interactive modules and support via private Instagram groups. The goal is to see if the program is engaging, acceptable, and feasible, not yet whether it reduces opioid use. 70 people will take part, with half getting the intervention and half serving as a control group.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
peer-led social media intervention on Instagram
What this could lead to
If successful, this could provide a scalable, low-cost way to reduce risky opioid use among young adults through social media.
What could go wrong
This is a very small pilot study (70 people) testing feasibility, not effectiveness. It may not show clear benefits or be generalizable to other groups.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PAST-3-MONTH NON-MEDICAL USE OF PRESCRIPTION OPIOIDS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

opioid abuse Psychological Well-Being

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PAST-3-MONTH NON-MEDICAL USE OF PRESCRIPTION OPIOIDS SOCIAL MEDIA USERS WITHOUT SUBSTANCE USE DISORDERS YOUNG ADULTS

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-••••

Locations

  • University of South Carolina

    Columbia, South Carolina, 29208, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

More trials for these conditions

Other studies related to the condition(s) this trial covers.